[HTML][HTML] Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL

J Zha, H Harada, E Yang, J Jockel, SJ Korsmeyer - Cell, 1996 - cell.com
J Zha, H Harada, E Yang, J Jockel, SJ Korsmeyer
Cell, 1996cell.com
Extracellular survival factors alter a cell's susceptibility to apoptosis, often through
posttranslational mechanisms. However, no consistent relationship has been established
between such survival signals and the BCL-2 family, where the balance of death agonists
versus antagonists determines susceptibility. One distant member, BAD, heterodimerizes
with BCL-X L or BCL-2, neutralizing their protective effect and promoting cell death. In the
presence of survival factor IL-3, cells phosphorylated BAD on two serine residues …
Abstract
Extracellular survival factors alter a cell's susceptibility to apoptosis, often through posttranslational mechanisms. However, no consistent relationship has been established between such survival signals and the BCL-2 family, where the balance of death agonists versus antagonists determines susceptibility. One distant member, BAD, heterodimerizes with BCL-XL or BCL-2, neutralizing their protective effect and promoting cell death. In the presence of survival factor IL-3, cells phosphorylated BAD on two serine residues embedded in 14-3-3 consensus binding sites. Only the nonphosphorylated BAD heterodimerized with BCL-XL at membrane sites to promote cell death. Phosphorylated BAD was sequestered in the cytosol bound to 14-3-3. Substitution of serine phosphorylation sites further enhanced BAD's death-promoting activity. The rapid phosphorylation of BAD following IL-3 connects a proximal survival signal with the BCL-2 family, modulating this checkpoint for apoptosis.
cell.com